Image of Phase 1 of Alexion's development near Mulhuddart, Co. Dublin, Ireland. The Phase 2 bulk biologics development is currently in construction.
PES is delighted to be supporting Alexion on Phase 2 of their bulk biologics facility in north County Dublin, Ireland, where we are providing C&Q and Automation management support.
Alexion is a US pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases.